Skip to main
NBIX
NBIX logo

Neurocrine Biosciences (NBIX) Earnings Dates & Reports

Neurocrine Biosciences (NBIX) Most Recent Earnings

Report DateMay 5, 2025
Period EndingQ1 2025
Est. EPS$1.09
Actual EPS$0.70
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Neurocrine Biosciences (NBIX) Earnings per Share (EPS) History

Signup for full access
Browse free

Neurocrine Biosciences (NBIX) Latest Earnings

The value each NBIX share was expected to gain vs. the value each share gained.

Neurocrine Biosciences (NBIX) reported its most recent earnings on May 5, 2025 for Q1 2025, posting earnings per share (EPS) of $0.70. This exceeded analysts' expectations of $1.09 by 35.78%, marking a Miss.

For comparison, Neurocrine Biosciences reported EPS of $1.20 in the same quarter last year.

The company is expected to announce its next earnings report on 07/31/2025, with analysts projecting an EPS of $1.50.

Neurocrine Biosciences (NBIX) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2025Jul 31, 2025
$1.50Next earnings call Jul. 31, 2025
Q1 2025May 5, 2025
$1.09$0.70-35.78%
DeckReportListen
Q4 2024Feb 6, 2025
$1.71$1.69-1.17%
Q3 2024Oct 30, 2024
$1.51$1.81+19.87%
Q2 2024Aug 1, 2024
$1.03$1.63+58.25%
View all

Neurocrine Biosciences (NBIX) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Neurocrine Biosciences’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
May 5, 2025
Feb 6, 2025
Oct 30, 2024
Aug 1, 2024

Neurocrine Biosciences (NBIX) Earnings FAQs

Neurocrine Biosciences (NBIX) last reported earnings on May 5, 2025 for Q1 2025, posting an EPS of $0.70, which Miss the estimate of $1.09 by 35.78%.

For Q1 2025, Neurocrine Biosciences (NBIX) reported an EPS of $0.70, missing analysts' estimate of $1.09 by 35.78%.

For Q1 2025, Neurocrine Biosciences (NBIX) Miss expectations with an actual EPS of $0.70 vs. an estimated EPS of $1.09.

Following the last earnings report on May 5, 2025, Neurocrine Biosciences (NBIX)'s stock price moved — from — to —.

The next Neurocrine Biosciences (NBIX) earnings call is scheduled for Jul. 31, 2025, where executives will discuss financial results and outlook.

Neurocrine Biosciences (NBIX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.